Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950103-25-005611
Filing Date
2025-05-01
Accepted
2025-05-01 19:59:04
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 6098
  Complete submission text file 0000950103-25-005611.txt   7627
Mailing Address 300 VESEY STREET NEW YORK NY 10282
Business Address
Novogratz Michael (Filed by) CIK: 0001380615 (see all company filings)

Type: SCHEDULE 13G

Mailing Address 3030 ROCKY POINT DRIVE SUITE 420 TAMPA FL 33607
Business Address 3030 ROCKY POINT DRIVE SUITE 420 TAMPA FL 33607 701-353-5425
UPEXI, INC. (Subject) CIK: 0001775194 (see all company filings)

EIN.: 833378978 | State of Incorp.: NV | Fiscal Year End: 0630
Type: SCHEDULE 13G | Act: 34 | File No.: 005-93404 | Film No.: 25905126
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)